191 related articles for article (PubMed ID: 31352240)
1. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.
Gupta P; Mohammad T; Khan P; Alajmi MF; Hussain A; Rehman MT; Hassan MI
Biomed Pharmacother; 2019 Oct; 118():109245. PubMed ID: 31352240
[TBL] [Abstract][Full Text] [Related]
2. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy.
Gupta P; Mohammad T; Dahiya R; Roy S; Noman OMA; Alajmi MF; Hussain A; Hassan MI
Sci Rep; 2019 Dec; 9(1):18727. PubMed ID: 31822735
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor.
Khairat SHM; Omar MA; Ragab FAF; Roy S; Turab Naqvi AA; Abdelsamie AS; Hirsch AKH; Galal SA; Hassan MI; El Diwani HI
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100080. PubMed ID: 34128259
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase.
Gulzar M; Syed SB; Khan FI; Khan P; Ali S; Hasan GM; Taneja P; Hassan MI
Int J Biol Macromol; 2019 Feb; 122():1297-1304. PubMed ID: 30227205
[TBL] [Abstract][Full Text] [Related]
6. Functional implications of pH-induced conformational changes in the Sphingosine kinase 1.
Gupta P; Khan FI; Roy S; Anwar S; Dahiya R; Alajmi MF; Hussain A; Rehman MT; Lai D; Hassan MI
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 225():117453. PubMed ID: 31446356
[TBL] [Abstract][Full Text] [Related]
7. Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy.
Roy S; Khan S; Jairajpuri DS; Hussain A; Alajmi MF; Islam A; Luqman S; Parvez S; Hassan MI
J Biomol Struct Dyn; 2022 Sep; 40(14):6350-6362. PubMed ID: 33565370
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
[TBL] [Abstract][Full Text] [Related]
9. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
[TBL] [Abstract][Full Text] [Related]
10. PF543-like compound, a promising sphingosine kinase 1 inhibitor: Structure-based virtual screening and molecular dynamic simulation approaches.
Shahwan M; Hassan N; Ashames A; Alrouji M; Alhumaydhi F; Al Abdulmonem W; Muhsinah AB; Furkan M; Khan RH; Shamsi A; Atiya A
Int J Biol Macromol; 2023 Aug; 245():125466. PubMed ID: 37348582
[TBL] [Abstract][Full Text] [Related]
11. Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition.
Shakeel I; Khan S; Roy S; Sherwani F; Ahmad SF; Sohal SS; Afzal M; Hassan MI
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127036. PubMed ID: 37788733
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2-epi-jaspine B analogs as selective sphingosine kinase 1 inhibitors.
Yang H; Li Y; Chai H; Yakura T; Liu B; Yao Q
Bioorg Chem; 2020 May; 98():103369. PubMed ID: 31703810
[TBL] [Abstract][Full Text] [Related]
13. Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer.
Khan FI; Lai D; Anwer R; Azim I; Khan MKA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):172-186. PubMed ID: 31752564
[TBL] [Abstract][Full Text] [Related]
14. Second generation of pyrimidin-quinolone hybrids obtained from virtual screening acting as sphingosine kinase 1 inhibitors and potential anticancer agents.
Vettorazzi M; Díaz I; Angelina E; Salido S; Gutierrez L; Alvarez SE; Cobo J; Enriz RD
Bioorg Chem; 2024 Mar; 144():107112. PubMed ID: 38237390
[TBL] [Abstract][Full Text] [Related]
15. Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure-activity relationship study of 4-epi-jaspine B.
Ohno H; Honda M; Hamada N; Miyagaki J; Iwata A; Otsuki K; Maruyama T; Nakamura S; Nakanishi I; Inuki S; Fujii N; Oishi S
Bioorg Med Chem; 2017 Jun; 25(12):3046-3052. PubMed ID: 28408190
[TBL] [Abstract][Full Text] [Related]
16. Investigation of guanidinium chloride-induced unfolding pathway of sphingosine kinase 1.
Gupta P; Khan FI; Ambreen D; Lai D; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2020 Mar; 147():177-186. PubMed ID: 31917989
[TBL] [Abstract][Full Text] [Related]
17. A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay.
Kashem MA; Kennedy CA; Fogarty KE; Dimock JR; Zhang Y; Sanville-Ross ML; Skow DJ; Brunette SR; Swantek JL; Hummel HS; Swindle J; Nelson RM
Assay Drug Dev Technol; 2016; 14(1):39-49. PubMed ID: 26426296
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.
Roy S; Mohammad T; Gupta P; Dahiya R; Parveen S; Luqman S; Hasan GM; Hassan MI
ACS Omega; 2020 Sep; 5(34):21550-21560. PubMed ID: 32905276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
